Company / Operating Income
Pacira BioSciences, Inc. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$19.2M
FY2025
5-year range
-$73.4M / $87.7M
FY2021-FY2025
Trend
+126.2%
vs FY2024
Sector context
#52 of 204
Health Care
What the data says
Pacira BioSciences, Inc.'s operating income of $19M is higher than 75% of companies in the Health Care sector (FY2025). Operating Income has fluctuated over the past 10 years, ranging from -$73M in FY2024 to $88M in FY2023.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of +3.8%.
Declined from $88M to $19M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -31.6%
- 5-Year CAGR
- +3.8%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 204This company $19.2M Sector average $107.8M
▼
-82.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +3.8%, indicating consistent growth.
- In FY2025, operating income increased 126.2% year-over-year.
- Ranks #52 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $19.2M | +126.2% |
| FY2024 | -$73.4M | -183.7% |
| FY2023 | $87.7M | +46.1% |
| FY2022 | $60.0M | +472.7% |
| FY2021 | $10.5M | -34.2% |
| FY2020 | $15.9M | +163.8% |
| FY2019 | -$24.9M | +22.1% |
| FY2018 | -$32.0M | -438.7% |
| FY2017 | $9.5M | +129.5% |
| FY2016 | -$32.0M | -438.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026